The content on this site is intended for healthcare professionals only
The pharmacovigilance system oversees medicine safety in Zambia under the ZA Medicines Regulatory Authority, requiring marketing authorisation holders to establish safety monitoring systems.
Healthcare workers are trained and equipped with reporting tools. While there are no specific requirements for cancer medicines, there is a push for better engagement and training in pharmacovigilance. The system focusses on serious adverse drug reactions, especially for new drugs, and utilises both paper and electronic reporting tools.
Understanding Zimbabwe's pharmacovigilance system
The evolution of pharmacovigilance: Lessons from thalidomide
Understanding pharmacovigilance challenges in Lesotho & Swaziland
Understanding Uganda's drug safety regulations
Understanding pharmacovigilance in Namibia
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers
Improving results of FNAC in thyroid nodules
Remote access thyroid surgery
